Enlivex Ltd.

IPO

Enlivex | Quality Longevity & Prediction Markets Treasury

Enlivex Ltd. was founded in 2005, is headquartered in Ness Ziona, Israel, lists 11–50 employees, and has $225.2M in recorded funding across 3 rounds.

Headquarters
Ness Ziona
Employees
11–50
Founded
2005
Business Model
B2B
Total Funding
$225.2M
Last Round
$5.2M BridgeSep 2018
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 1 investor for this company. The full record is or through the API.

About

Enlivex is a Nasdaq-listed clinical-stage immunotherapy company developing Allocetra™, an off-the-shelf macrophage reprogramming cell therapy targeting inflammatory diseases including age-related knee osteoarthritis. Phase II data demonstrated 72% pain reduction and 109% functional improvement across over 250 patients, addressing a market valued at over $314 billion.

Summary

Enlivex Ltd. is a Biotech company based in Ness Ziona, Israel, founded in 2005. It lists 11–50 employees. It has raised $225.2M in total across 3 rounds, most recently a $5.2M Bridge round in Sep 2018. Investors include KIP Global Pharma Private Equity Fund.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOMar 2019

Sign up to see all 4 events

Funding: Bridge. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Enlivex Ltd. on Indexed.vc
<a href="https://indexed.vc/companies/enlivex-ltd"><img src="https://indexed.vc/api/badge/company/enlivex-ltd" alt="Enlivex Ltd. on Indexed.vc" width="260" height="76" /></a>